Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 12Recruiting 10Terminated 5Active not recruiting 4Unknown 3Not yet recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Breast Neoplasms 704Carcinoma, Non-Small-Cell Lung 470Prostatic Neoplasms 420Neoplasms 380Multiple Myeloma 264Colorectal Neoplasms 261Lung Neoplasms 247Neoplasm Metastasis 229Melanoma 215Ovarian Neoplasms 191Leukemia, Myeloid, Acute 189Pancreatic Neoplasms 182Squamous Cell Carcinoma of Head and Neck 163Recurrence 147Carcinoma, Renal Cell 145Lymphoma 142Glioblastoma 138Lymphoma, Non-Hodgkin 135Stomach Neoplasms 128Triple Negative Breast Neoplasms 127Brain Neoplasms 124Carcinoma, Hepatocellular 123Leukemia, Lymphocytic, Chronic, B-Cell 122Uterine Cervical Neoplasms 117Head and Neck Neoplasms 117Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Urinary Bladder Neoplasms 113Lymphoma, Large B-Cell, Diffuse 105Sarcoma 102Lymphoma, Follicular 100

Interventions

envafolimab 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Advanced or Metastatic Solid Tumors × Clear all
NCT06074497 2026-04-29

This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors.

Kangabio AUSTRALIA LTD PTY

Phase 1 Active not recruiting
54 enrolled
Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT06548217 2025-07-03

A Phase I Study of ONO-4538HSC in Subjects With Advanced or Metastatic Solid Tumors

Ono Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
31 enrolled
Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT03155061 2025-06-05

Study of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors

Ono Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
183 enrolled
Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT05399654 2024-08-16

INCLINE-101

Tallac Therapeutics

Phase 1/2 Active not recruiting
72 enrolled
Other solid neoplasm

Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡